Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Second sight for blindness

20.04.2004


Utilising the same principle that lets a TV camera transform external images into electric signals, IST project OPTIVIP has tested an implantable visual prosthesis to stimulate the optic nerve and allow limited sight for certain sufferers of blindness.



The method used by the four-year project is based on the stimulation of the optic nerve by a cuff electrode. The prosthesis is operational only if the optic nerve is still healthy in spite of the complete blindness. For this reason, OPTIVIP has targeted retinitis pigmentosa, a disease that leads to the premature ageing and a disappearance of the retina receiving cells that leads to blindness over time. Hereditary in 60 per cent of the cases, it occurs to roughly 1 out of every 5,000 women and 1 out of every 4,000 men.

The origins of the project can be traced to February 1998, when within the framework of the ESPRIT project MiViP, an electrode designed to stimulate the optic nerve was implanted in a volunteer who was completely blind due to retinitis pigmentosa. The use of this electrode made possible the electrical stimulation of the optic nerve by means of external equipment. This revealed numerous successful visual perceptions called phosphenes, which are apparitions of luminous sensations, and it was decided to implant a telemetrically controlled neurostimulator in the same patient.


Following up these discoveries, the OPTIVIP project developed a system that works in the following ways. A small camera fastened on glasses picks up an image of what appears in the direction of the glance. The components of the prosthesis are connected between the camera and the stimulation electrode, which contains eight contacts that sends signals to some packets of optic nerve fibres, provoking the phosphenes.

The implanted stimulator produces the electric currents that are applied to the contacts of the electrode according to orders transmitted by the antenna. The heart of the implanted stimulator is a specific integrated circuit that takes care of the demodulation functions of the signal received from the antenna, formats the stimulation currents, and takes measurements. Its electric power is provided through a transcutaneous link (ie a small transformer with coils that act as antennas) implanted behind the ear and the outside.

After learning how to control the visual sensations generated by the optic nerve stimulation, OPTIVIP developed some practical uses of the system, which it documented in a report published in October 2003. Shapes or characters projected on a screen can now be recognised by the patient thanks to the prosthesis. During a recognition test of one out of 45 patterns, 87 per cent of the answers were correct. The report concluded that the implantation brought "good results" and the consortium has "made a step forward" from the original tests.

"Thanks to this system, our volunteer has leaned how to recognise signs looking like block capitals. In a simplified environment, she can also identify objects laying on a table and grasp them thanks to the prosthesis," says Claude Veraart, head of biomedical aspects within the project. While these results may seem modest, he adds that they are important insofar as numerous possibilities of improvement have been identified. Also, important is the fact that the system is perfectly tolerated by the wearer. No deterioration could be noticed during the five years of evaluation, due to the use of biocompatible materials that resist their environment without aggressing it.

With such a promising future, "it was decided to continue the work while widely improving the system technically and carrying out an implantation in several new volunteers," says Charles Trullemans, head of system engineering for the project. "From the technical point of view, the prototypes are close to being delivered for implantation. From the biomedical point of view, the implantation is going to occur within a few months." However, he notes the project is a pre-clinical test, and that actual commercialisation is not foreseen for several years.

Beyond the implanted prosthesis, the consortium sees additional potential for the technology that is being developed. According to them, the results of the project will in a short time enable the availability of several products in a wider application field, such as electrodes for neural stimulation, neuronal stimulators with high-speed, bi-directional transcutaneous links for general use, and several models of external processors with high computing power.

Contact:
Charles Trullemans
Université Catholique de Louvain
DICE - Unite des Dispositifs et Circuits Electroniques
1 Place de l’Université
B-1348 Louvain-la-Neuve
Belgium
Tel: +32-10-472567
Fax: +32-10-472598
Email: Ctrullemans@dice.ucl.ac.be

Source: Based on information from OPTIVIP

Tara Morris | IST Results
Further information:
http://istresults.cordis.lu/index.cfm?section=news&tpl=article&ID=64743

More articles from Health and Medicine:

nachricht Vanishing capillaries
23.03.2017 | Technische Universität München

nachricht How prenatal maternal infections may affect genetic factors in Autism spectrum disorder
22.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short

23.03.2017 | Life Sciences

Researchers use light to remotely control curvature of plastics

23.03.2017 | Power and Electrical Engineering

Sea ice extent sinks to record lows at both poles

23.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>